Eur Arch Otorhinolaryngol:过敏性鼻炎如何影响COVID-19的严重程度?

2021-05-18 AlexYang MedSci原创

2019年12月,中国武汉市出现导致急性呼吸窘迫综合症(ARDS)的SARS-CoV-2,并成为一种迅速蔓延的大流行病。2020年2月11日,世界卫生组织(WHO)命名由这种新型冠状病毒导致的疾病为2

2019年12月,中国武汉市出现导致急性呼吸窘迫综合症(ARDS)的SARS-CoV-2,并成为一种迅速蔓延的大流行病。2020年2月11日,世界卫生组织(WHO)命名由这种新型冠状病毒导致的疾病为2019年冠状病毒病(COVID-19)。世卫组织于2020年3月11日宣布COVID-19为大流行病。截至2020年12月,即疫情开始一年后,全球范围内的感染病例总数为8100万,全球约有200万人死亡。

COVID-19最常见的症状是发烧、咳嗽、疲劳和呼吸困难。COVID-19是一种传染性的、有时是致命的疾病,其症状也是新描述的。相比之下,过敏性鼻炎是一种慢性疾病,不具有传染性,没有致死的可能性,其症状已被充分描述。一些过敏性疾病,包括哮喘,已经被定义为是COVID-19的不良后果的风险因素。

近期,有研究人员调查了过敏性鼻炎在COVID-19的严重程度中的作用

这项病例对照研究于2020年3月18日至8月30日在萨卡里亚教育和研究医院、丰田医院和Yenikent州立医院进行。研究包括一个病例组和一个对照组,病例组是随机选择的125名诊断为过敏性鼻炎的患者,对照组是诊断为COVID-19的125名无过敏性鼻炎患者。研究人员评估了所有参与者在吸烟、症状和住院方面的情况,以及他们的住院时间和合并症的数量。

结果发现,两组之间在无症状患者的百分比(P=0.27)、是否吸烟(P=0.068)、住院情况(P=0.79)和住院时间(P=0.55)方面没有统计学上的显著差异。每组中各有两名患者需要在重症监护室(ICU)接受护理。病例组的一名患者和对照组的两名患者因COVID-19而死亡。

描述性特征比较

综上所述,过敏性鼻炎并不影响COVID-19的严重程度。然而,建议通过对患有过敏性鼻炎的COVID-19患者的预后的进一步研究来验证该研究的结论。

原始出处:

Ali Guvey. How does allergic rhinitis impact the severity of COVID-19?: a case-control study. Eur Arch Otorhinolaryngol. May 2021

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 拿着枪的小啰啰

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 12582d2fm84暂无昵称

    真的不这么认为

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 ms1000000055856980

    很赞,谢谢!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 ms5000000592303725

    涨知识

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 phoebeyan520

    学习了,谢谢

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 青峰弈谷

    不错

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 wxl882001

    了解

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2047412, encodeId=4dcf204e412bc, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Sep 23 02:43:49 CST 2021, time=2021-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967101, encodeId=ce1796e10194, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/05/49dbda1c7803de9dd7c04cdf52fa2202.jpg, createdBy=2d225218913, createdName=拿着枪的小啰啰, createdTime=Wed May 19 23:12:39 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966991, encodeId=12429669913f, content=真的不这么认为, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0acb2570971, createdName=12582d2fm84暂无昵称, createdTime=Wed May 19 18:57:58 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966845, encodeId=7d0396684545, content=很赞,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb155504115, createdName=ms1000000055856980, createdTime=Wed May 19 11:43:47 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966807, encodeId=81a296680ecb, content=涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210519/87b24267a46247cb85ab9e8cd1f0328b/975d91789a624aa48f6189067b12d6d0.jpg, createdBy=a9a65437198, createdName=ms5000000592303725, createdTime=Wed May 19 10:09:16 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966794, encodeId=6af7966e94d5, content=学习了,谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Wed May 19 09:26:14 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966692, encodeId=a65096669294, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/c1899a05ca9c44b88c648bb52a2f82a9/b43f760eb0bc4f76adcf0d7d4714b5e7.jpg, createdBy=cc215461466, createdName=青峰弈谷, createdTime=Tue May 18 23:17:52 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966679, encodeId=7f639666e9d3, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Tue May 18 22:24:20 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966674, encodeId=83529666e4e7, content=真让人大开眼界, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cc35503886, createdName=ms8000000197177051, createdTime=Tue May 18 22:16:32 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 ms8000000197177051

    真让人大开眼界

    0

相关资讯

Nutrients:益生菌混合物用来预防儿童过敏性鼻炎症状

过敏性疾病在成人和儿童中越来越多。因其存在严重并发症的风险、导致生活质量低下和引起相关费用,因而它是一个公共卫生问题。据估计,超过20%的人口受过敏性疾病的影响,如过敏性鼻炎(AR)、哮喘、食物过敏和

World Allergy Organ J:慢性鼻炎中过敏性鼻炎的鉴定

由于过敏性鼻炎(AR)和非过敏性鼻炎(NAR)的临床表现相似,在临床实践中很难进行区分。

Eur Arch Otorhinolaryngol:鼻内类固醇对常年过敏性鼻炎患者的鼻炎症状、睡眠质量和生活质量的影响

最近,有研究人员评估了常年过敏性鼻炎(PAR)对健康相关生活质量(HRQL)的影响,衡量了PAR患者主要关注的问题,以及确定了鼻内类固醇(INS)对PAR和相关的鼻塞、睡眠障碍和白天嗜睡的影响。

PLoS One:6-8岁儿童过敏性鼻炎的风险因素分析

在过去的30年中,台湾地区的过敏性鼻炎(AR)发病率迅速增加;然而,过敏性鼻炎的潜在风险因素还没有研究。

J Allergy Clin Immunol:鼻腔内铅含量是过敏性鼻炎的加重的原因之一

空气污染物被质疑会影响过敏性鼻炎(AR)的病理状况。

Clin Exp Allergy:欧洲过敏性鼻炎药物治疗的差异研究

过敏性鼻炎(AR)是最常见的慢性疾病之一。现有的治疗方法包括过敏原逃避、使用H1-抗组胺药或鼻内皮质类固醇(INCS)的药物治疗和过敏原特异性免疫治疗(AIT)。